Advertisement
Advertisement

ARAY

ARAY logo

Accuray Incorporated

0.28
USD
Sponsored
-0.02
-5.70%
May 14, 15:59 UTC -4
Closed
exchange

After-Market

0.29

0.00
+1.47%

Accuray Incorporated Profile

About

Accuray Inc. designs, develops & sells radiosurgery and radiation therapy systems for treatment of tumors in the body. The company's product suite includes the CyberKnife Systems and the TomoTherapy Systems. It primarily generates revenues by selling the CyberKnife & TomoTherapy Systems and providing ongoing services and upgrades to customers following installation of the CyberKnife System. Product revenues include sales of linacs for other uses. It also offers optional hardware and software, technical enhancements and upgrades to the CyberKnife & TomoTherapy System. The CyberKnife Systems include: the CyberKnife G4, CyberKnife VSI System and the new CyberKnife M6 Series System. TomoTherapy Systems include the Hi-Art System, delivering CT-guided, helical intensity modulated radiation therapy; the TomoHD System and the Tomo H Series Systems.

Info & Links

CEO

Suzanne Winter

Headquarters

1240 Deming Way
MADISON, WI 53717, UNITED STATES

Industry

Medical Instruments

Sector

Medical

Website

www.accuray.com

Auditor

GRANT THORNTON LLP

Share holders

164

Employees

990

Accuray Incorporated Statistics

Valuation Measures

Market Capitalization2

34.38M

Enterprise Value

128.40M

Enterprise Value/EBITDA(ttm)

-20.87

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

0.11

Price to Book(mrq)

0.94

Price to Cash(ytd)

9.44

Profitability

Gross Margin(ttm)

27.57%

Operating Margin(ttm)

-8.42%

Profit Margin(ttm)

-9.20%

Return on Equity(ttm)

-59.81%

Return on Invested Capital(ttm)

-19.24%

Return on Assets(ttm)

-7.91%

Income Statement

Revenue(ttm)

436.97M

Revenue Per Share(ttm)

3.68

Gross Profit(ttm)

121.23M

EBITDA(ttm)3

-6.15M

Net Income Available to Common(ttm)

-35.62M

Diluted EPS(ttm)

-0.29

Share Statistics

Beta (5Y Monthly)

1.32

52-Week Change

-82.84%

S&P 500 52-Week Change

26.78%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

118.78M

Dividend Yield

0.00%

Float4

113.60M

% Held by Insiders

4.36%

% Held by Institutions

64.08%

Balance Sheet

Total Cash(mrq)

41.87M

Total Cash Per Share(mrq)

0.35

Total Debt(mrq)

135.89M

Total Debt/Equity(mrq)

254.37%

Current Ratio(mrq)

1.47%

Quick Ratio(mrq)

0.71%

Book Value Per Share(mrq)

0.45

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.03

Free Cash Flow(ytd)

-8.73M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement